cont...
✨Upa U-ACHIEVE maint
✨IL-23🧬
✨Delayed respndrs w risa in #CrohnsDisease
✨Miri & fatigue
✨VEGA combo tx study in UC
✨Upa vs Vedo 4 induction in #UlcerativeColitis

1️⃣#UEGWeek webinar 👇
2️⃣⏭Then watch Q&A👆⚙️Get the nuts & bolts on the data🔩

---
RT @MondayNightIBD
🙌 @my_ueg X #MondayNightIBD 🙌◦◦◦◦◦◦◦◦◦◦◦◦🎯 Best of #UEGWeek ◦◦◦◦ CME🔗http://bit.ly/MNIBD-UEG2022 ◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦ Support by edu grants from @abbvie & B…
https://twitter.com/MondayNightIBD/status/1619349630994776065

#MondayNightIBD #GITwitter @my_ueg @BonumCe

⏮#ICYMI +replay full #webinar👇

🔦Top #IBD #UEGWeek abstracts🔦
✨Ozanimod True North extension study
✨ELEVATE-UC 12 & 52 of etrasimod
✨LADI ada dose interval study
✨Tofa RWE in #UlcerativeColitis
cont...👇

8/#MondayNightIBD #UEGWeek

👇#PostConvo #IBDPoll 4⃣
🟢The U-ACHIEVE Maintenance study, looked @ pts w UC who responded to induction tx w upadacitinib @ 8wks
Which tx group led to greater clinical remission per adapted Mayo score at wk 52 compared to PBO?

6/#MondayNightIBD #UEGWeek

👇#PostConvo #IBDPoll 2⃣
🟢Which drug combo were given in the Ph2a VEGA study to show the potential of dual inhibition of IL-23 & TNFα to more effectively induce CR & remission in pts w mod-sev UC?

7/#MondayNightIBD #UEGWeek

👇#PostConvo #IBDPoll 3⃣
🟢Which of the following PRO questionnaires assesses pt fatigue using a 13-item tool & 5-point scale, where a ⬆️higher score indicates a better pt outcome?

🔥Best of #UEGWeek #IBD 🔥📟@my_ueg champions & welcome💬 @hlcortezpinto @maloehr1 @PatriziaBurra @pilar_acedo @joostphdrenth @DinaTiniakos @WafaaKhannoussi @LuRicciardiello @DignassAxel @frankbalaguer @Gio_Marchegiani @DeMadaria @KM_Pawlak @KralJan @BlanariuGilca @ign76

5/#MondayNightIBD #UEGWeek

👇#PostConvo #IBDPoll 1️⃣
🟢In the True North open-label extension, the findings indicated that approx 1/2 the pts who failed to achieve a CR after 10wks of ozanimod induction tx benefitted from which of the following:

⭐️Great #UEGWeek #IBD abstracts
📟org authors & welcoming💬! @AndresYarur @PeyrinBiroulet @silvio_silvio75 @RPanaccione @IBD_Afzali @mchiorean4 @bruce_sands1 @IBDMD @HedinCharlotte @SeverineVermei1

#GITwitter #MondayNightIBD
⭐️⭐️⭐️NOW - Best of #IBD @ #UEGWeek Q&A w all-star faculty ⭐️⭐️⭐️
In collab w @my_ueg
TWEET your❓❓❓below ⬇️
Supported by edu grants from @abbvie & BMS⭐️⭐️⭐️

Join now w/ @CharlieMuz @DCharabaty @Iris_Dotan @MRegueiroMD

📲Tweet your❓below

4/#MondayNightIBD #UEGWeek
🇺🇸🇬🇧🇮🇱🇦🇹🇨🇦🇫🇷🇩🇪🇮🇹🇨🇳🇯🇵🇦🇺🇬🇹🇲🇽🇧🇷
📍Where are you joining from?

3/#MondayNightIBD #UEGWeek

📍Where are you in your career?

🔔Set your⏰
🗓TODAY, Mon 30 Jan @ 🇺🇸 2-2:30p ET/11a PT
🇪🇺7p GMT/8p CEST

⭐️Best of #IBD from #UEGWeek
👉🙋🏻LIVE Q&A w @Iris_Dotan @CharlieMuz @MRegueiroMD & @DCharabaty

📲Tweet your❓b4 & during the session
🗒Abstracts discussed📸👇
#CME ℹ️http://bit.ly/3XgqsH8

#ICYMI 🎥🔗👇
---
RT @MondayNightIBD
🙌 @my_ueg X #MondayNightIBD 🙌◦◦◦◦◦◦◦◦◦◦◦◦🎯 Best of #UEGWeek ◦◦◦◦ CME🔗http://bit.ly/MNIBD-UEG2022 ◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦ Support by edu gran…
https://twitter.com/MondayNightIBD/status/1619349630994776065

8/#MondayNightIBD #UEGWeek @my_ueg @BonumCe

🚨Don’t forget the Live Q+A🚨
🗓️Mon. Jan 30
⏰14:00 (2p) EST / 19:00 GMT / 20:00 CEST

📺 Join experts @CharlieMuz @Iris_Dotan @MRegueiroMD & @DCharabaty

🙋‍♀️🙋🏽🙋🏻🙋🏾‍♀️🙋🙋‍♀️🙋🏽🙋🏻🙋🏾‍♀️🙋🙋‍♀️🙋🏽🙋🏻🙋🏾‍♀️🙋

📲✍️ Tweet your ❓ to be discussed on Mon👇

5/#MondayNightIBD #UEGWeek
#CME🔗http://bit.ly/3XgqsH8
📲Tweet your❓for Mon LIVE Q&A

👇#IBDPoll 2⃣
🟢Which drug combo were given in the Ph2a VEGA study to show the potential of dual inhibition of IL-23 & TNFα to more effectively induce CR & remission in pts w mod-sev UC?

7/#MondayNightIBD #UEGWeek
#CME🔗http://bit.ly/3XgqsH8

👇#IBDPoll 4⃣
🟢The U-ACHIEVE Maintenance study, looked @ pts w UC who responded to induction tx w upadacitinib @ 8wks

Which tx group led to greater clinical remission per adapted Mayo score at wk 52 compared to PBO?

6/#MondayNightIBD #UEGWeek
📲Tweet your❓for Mon LIVE Q&A @ 2p ET/ 7p GMT/ 8p CEST

👇#IBDPoll 3⃣
🟢Which of the following PRO questionnaires assesses pt fatigue using a 13-item tool & 5-point scale, where a ⬆️higher score indicates a better pt outcome?

3/ #MondayNightIBD X #UEGWeek 2022 Best in #IBD

✨Faculty @Iris_Dotan, @CharlieMuz, @MRegueiroMD, & @DCharabaty ✨

🤝 In collab w/ @my_ueg, @BonumCe

🆓#CME🔗http://bit.ly/3XgqsH8

📲Tweet you questions👇🏽to be answered LIVE by the experts Monday Jan 30 2pmET/ 7pmGMT/ 8pmCEST

4/#MondayNightIBD #UEGWeek
🆓 #CME🔗http://bit.ly/3XgqsH8

👇#IBDPoll 1️⃣
🟢In the True North open-label extension, the findings indicated that approx 1/2 the pts who failed to achieve a CR after 10wks of ozanimod induction tx benefitted from which of the following:

4/#MondayNightIBD #UEGWeek
🆓 #CME🔗http://bit.ly/3XgqsH8

👇#IBDPoll 1️⃣
🟢In the True North open-label extension, the findings indicated that approx 1/2 the pts who failed to achieve a CR after 10wks of ozanimod induction tx benefitted from which of the following:

🙌 @my_ueg X #MondayNightIBD 🙌◦◦◦◦◦◦◦◦◦◦◦◦🎯 Best of #UEGWeek ◦◦◦◦ CME🔗http://bit.ly/MNIBD-UEG2022 ◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦ Support by edu grants from @abbvie & BMS https://twitter.com/i/broadcasts/1ynJOakvPpWKR